Fasting plasma glucose beats HbA1c for diabetes screening

January 17, 2013
Fasting plasma glucose beats HbA1c for diabetes screening
For patients without diabetes undergoing coronary angiography, fasting plasma glucose performs better in diabetes screening than glycated hemoglobin, according to a study published online Dec. 13 in Diabetes Care.

(HealthDay)—For patients without diabetes undergoing coronary angiography (CAG), fasting plasma glucose (FPG) performs better in diabetes screening than glycated hemoglobin (HbA1c), according to a study published online Dec. 13 in Diabetes Care.

Jun-Sing Wang, M.D., from the Taichung Veterans General Hospital in Taiwan, and colleagues compared HbA1c and FPG as screening tools for diabetes using an (OGTT) in 400 patients without known diabetes undergoing CAG. OGTT and HbA1c were assessed two to four weeks after hospital discharge.

The researchers note that 20.8 percent of the patients were diagnosed with diabetes. FPG had a higher area under the receiver operating characteristic curve than HbA1c (0.81 versus 0.73; P = 0.032). A proposed screening algorithm was validated in an additional group of 170 patients. The algorithm had a sensitivity of 74.4 percent and a specificity of 100 percent and reduced the number of OGTTs by 71.4 percent.

"In summary, we reported that the FPG test performed better than HbA1c in screening for diabetes in patients undergoing CAG," the authors write. "We proposed a screening algorithm, and its efficacy and practicability need further investigation."

Explore further: New insights in diagnosing diabetes may help the millions who are undiagnosed

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Sleep apnea severity linked to glycated hemoglobin levels

June 18, 2012

(HealthDay) -- For adults without diabetes, obstructive sleep apnea (OSA) severity is independently associated with impaired glucose metabolism, as measured by glycated hemoglobin (HbA1c) levels, according to a study published ...

Hemoglobin A1C inadequate for postpartum diabetes screening

June 19, 2012

(HealthDay) -- For postpartum women who have had gestational diabetes mellitus (GDM), the hemoglobin A1c (A1C) test criteria alone or in combination with fasting glucose test criteria does not provide sensitive and specific ...

Meds adherence self-report valid in type 2 diabetes

December 20, 2012

(HealthDay)—Self-reported measures of medication adherence in adults with type 2 diabetes are valid, although some self-reports are moderated by depression, according to a study published online Nov. 30 in Diabetes Care.

Recommended for you

New study reveals a novel protein linked to type 2 diabetes

August 16, 2016

Findings from Boston University School of Medicine (BUSM), which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes. A minority of obese individuals, ...

Gene variant explains differences in diabetes drug response

August 9, 2016

The first results from a large international study of patients taking metformin, the world's most commonly used type 2 diabetes drug, reveal genetic differences among patients that may explain why some respond much better ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.